6M
VNDA icon

6 Meridian’s Vanda Pharmaceuticals VNDA Stock Holding History

6 Meridian’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,607
Closed -$293K – 503
2021
Q2 		$293K Sell
13,607
-496
-4% -$8.88K 0.02% 230
2021
Q1 		$212K Sell
14,103
-10,464
-43% -$169K 0.02% 348
2020
Q4 		$323K Sell
24,567
-17
-0.1% -$205 0.03% 198
2020
Q3 		$237K Buy
24,584
+13,448
+121% +$144K 0.02% 224
2020
Q2 		$127K Sell
11,136
-16,081
-59% -$182K 0.01% 328
2020
Q1 		$282K Buy
+27,217
New +$337K 0.03% 390

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

6 Meridian's VNDA Position: Q3 2021 in Review

6 Meridian sold out of Vanda Pharmaceuticals (VNDA) in Q3 2021, closing a stake of 13,607 shares — an estimated $293K sold.

6 Meridian first reported a position in VNDA in Q1 2020 and held it in 6 quarters. The position peaked at $323K in Q4 2020. 182 funds tracked by Wall St. Rank hold VNDA as of Q3 2021.

  • 6 Meridian reported no remaining Vanda Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • 6 Meridian sold 13,607 Vanda Pharmaceuticals shares in Q3 2021, an estimated $293K.
  • 6 Meridian first reported a position in Vanda Pharmaceuticals in Q1 2020 and held it in 6 quarters.
  • 6 Meridian's Vanda Pharmaceuticals position peaked at $323K in Q4 2020.
  • 182 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2021.

Based on 6 Meridian's 13F filing for Q3 2021, filed 3 Nov 2021.